Latest Insider Transactions at Verona Pharma PLC (VRNA)
This section provides a real-time view of insider transactions for Verona Pharma PLC (VRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Verona Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Verona Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2021
|
Anders Ullman Director |
SELL
Open market or private sale
|
Direct |
10,800
-3.02%
|
$0
$0.99 P/Share
|
|
Jan 28
2021
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,824
+0.55%
|
-
|
|
Jan 28
2021
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
529,104
+2.57%
|
-
|